Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Larisa Janžič
Observed names:
Janžič, Larisa,
L. Janzic,
Larisa Janzic
Institution:
University of Ljubljana
Observed institution:
University of Ljubljana
ORCID:
0000-0002-0714-8206
Observed ORCID:
0000-0002-0714-8206
OpenAlex ID:
A5043450688
Biomarkers for prediction of CAR T therapy outcomes: current and future perspectives
2024
·
Lucija Levstek
, Larisa Janžič
, et al.
·
Frontiers in Immunology
·
80
PDF
Macrophage polarization during Streptococcus agalactiae infection is isolate specific
2023
·
Larisa Janžič
, Jernej Repas
, et al.
·
Frontiers in Microbiology
·
12
PARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in mice
2021
·
Masa Bosnjak
, Tanja Jesenko
, et al.
·
Bioelectrochemistry
·
12
PDF
Complement and inflammasome crosstalk in chronic inflammation
2026
·
Larisa Janžič
, Katarina Kouter
·
Frontiers in Immunology
·
9
PDF
Alterations in immunophenotype and metabolic profile of mononuclear cells during follow up in children with multisystem inflammatory syndrome (MIS-C)
2023
·
Andreja Nataša Kopitar
, Jernej Repas
, et al.
·
Frontiers in Immunology
·
5
Safety, long-term effectiveness, and immunogenicity of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapy
2025
·
Maša Bizjak
, Jakob Peterlin
, et al.
·
Vaccine X
·
3
CAR T therapy in adult DLBCL patients in Slovenia: Evaluation of predictive scores for outcomes and adverse events
2026
·
Lucija Sršen
, Irena Auersperger
, et al.
·
Human Vaccines & Immunotherapeutics
·
2
PDF
Mononuclear Aluminum–Fluoride Ions, AlFx(+/−)—Study of Plausible Frameworks of Complexes with Biomolecules and Their In Vitro Toxicity
2025
·
Anja Pavlovič
, Larisa Janžič
, et al.
·
Molecules
·
2
PDF
Combining Electrochemotherapy with Targeted Therapy Olaparib in vitro
2020
·
M. Bosnjak
, L. Janzic
, et al.
·
World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany
·
2
Corrigendum to “PARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in mice” [Bioelectrochemistry 2021 (140) 107832]
2021
·
Masa Bosnjak
, Tanja Jesenko
, et al.
·
Bioelectrochemistry
·
1
CAR-Cytotox: A Standardized Framework to Quantify Cytotoxic Potency in CAR T Cell Products
2026
·
Lucija Sr
, Larisa Janžič
, et al.
·
Research Square
PDF
Not all Group B Streptococci are alike: macrophage responses reveal inflammatory and immune-evasive strains
2026
·
Larisa Janžič
, Lucija Sršen
, et al.
·
Frontiers in Cellular and Infection Microbiology
PDF
CAR T therapy in adult DLBCL patients in Slovenia: Evaluation of predictive scores for outcomes and adverse events
2026
·
Sršen, Lucija
, Auersperger, Irena
, et al.
·
Figshare
Kombinacija elektrokemoterapije in zaviralcev poli (ADP-riboza) polimeraze (PARP) pri zdravljenju raka dojke
2019
·
Larisa Janžič
·
Repository of the University of Ljubljana (University of Ljubljana)
Vpliv nanodelcev paladija na razvoj kalic enokaličnic in dvokaličnic
2018
·
Urša Adamič
, Andraž Dolar
, et al.
·
Repository of the University of Ljubljana (University of Ljubljana)
Show more works
View as search
Works count:
16
Citation count:
128
H-index:
5
I10-index:
3
Year
Topic
Type